Skip to main content
. 2014 Nov 14;5(22):11133–11142. doi: 10.18632/oncotarget.2563

Table 4. Best Response – 5-FU + Cisplatin vs. Carboplatin + Paclitaxel.

Regimen N = 66 (%)
5-FU + Cisplatin (PF) 42 (63)
 Stable Disease 12 (29)
 Partial Response 24 (57)
 Progressive Disease 6 (14)
Carboplatin + Paclitaxel (CP) 24 (37)
 Stable Disease 5 (21)
 Partial Response 8 (33)
 Progressive Disease 11 (46)